mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.06 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.06 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.06 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.07 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.07 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |